Leptin in Sarcopenic Visceral Obesity: Possible Link between Adipocytes and Myocytes
Open accessThe DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
The combination of sarcopenia, age-related loss of muscle strength and mass, and obesity has been recognized as a new category of obesity among the elderly. Given that leptin has been hypothesized to be involved in the pathogenesis of sarcopenic obesity, we investigated the relationship between plasma leptin levels and thigh muscle sarcopenia and visceral obesity. Thigh muscle cross-sectional area (CSA) and visceral fat area were measured using computed tomography as indices for muscle mass and visceral fat, respectively, in 782 middle-aged to elderly subjects (303 men and 479 women), participating in a medical check-up program. Visceral obesity was defined as visceral fat area >100 cm², and sarcopenia was defined as < (one standard deviation--mean of thigh muscle CSA/body weight of young subjects [aged <50 years]).Thigh muscle CSA was significantly and negatively associated with plasma levels of leptin in both men (β = -0.28, p<0.0001) and women (β = -0.20, p<0.0001), even after correcting for other confounding parameters, including age, body weight, body height, visceral fat area, blood pressure, homeostatic model assessment index, and high sensitive C reactive protein. Subjects were divided into four groups based on presence or absence of sarcopenia or visceral obesity. Plasma levels of leptin were higher in subjects with sarcopenic visceral obesity than in those with either sarcopenia or visceral obesity alone. These findings indicate that sarcopenic visceral obesity is a more advanced, and suggest that leptin may link visceral obesity and sarcopenia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Obesity is a risk factor in developing other diseases such as cardiovascular diseases (atherosclerosis, myocardial infarct, heart failure, and coronary disease), metabolic syndrome, T2DM, NAFLD, cirrhosis, cancer, osteoarthritis, pulmonary dysfunction (e.g., obstructive sleep apnea syndrome), reduced cognitive skills, urinary incontinence, and, more recently, coronavirus disease 2019 (COVID-19) [”
From The critical role of oxidative stress in sarcopenic obesity (2021) · cites this paper as [43]
Experimental — accuracy not yet measuredIn the citing paper
“High leptin levels in aging and obesity upregulate the proinflammatory cytokines IL-6 and TNF-α, reducing insulin-like growth factor 1 (IGF1) activity and decreasing their anabolic actions on skeletal muscle [14, 43, 44].”
From The critical role of oxidative stress in sarcopenic obesity (2021) · cites this paper as [43]
In the citing paper
“Similar results were found in the K-NHANES and the sarcopenic obesity cohorts in East Asia, where visceral adipose tissue and thigh muscle ratios from CT scans were used [63,70].”
From Critical appraisal of definitions and diagnostic criteria for sarcopenic obesity based on a systematic review (2020) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Janssen, I., Heymsfield, S. B., & Ross, R. (2002) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2002.50216.x · Cited by 3,139 · cited 2×
“Sarcopenia was defined in both men and women as having CSA/BW within one standard deviation value of the CSA/BW distribution in subjects aged ,50 years among study participants [8,19].”
BackgroundMethodNew Criteria for `Obesity Disease' in Japan
The Examination Committee of Criter (2002) · Circulation Journal · doi:10.1253/circj.66.987 · Cited by 1,650
Sarcopenic obesity: definition, cause and consequences
Stenholm, S., Harris, T. B., Rantanen, T., Visser, M., Kritchevsky, S. B., & Ferrucci, L. (2008) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0b013e328312c37d · Cited by 1,070
Sarcopenic obesity: A new category of obesity in the elderly
Zamboni, M., Mazzali, G., Fantin, F., Rossi, A., & Di Francesco, V. (2008) · Nutrition, Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2007.10.002 · Cited by 953 · cited 1×
“Obesity, particularly visceral obesity, is a global pandemic known to be related to numerous pathological conditions, including metabolic syndrome, diabetes, hypertension, and cardiovascular disease”
BackgroundVisser, M., Kritchevsky, S. B., Goodpaster, B. H., Newman, A. B., Nevitt, M., Stamm, E., & Harris, T. B. (2002) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2002.50217.x · Cited by 845 · cited 1×
“In particular, sarcopenia in the legs leads to functional impairments such as postural instability, falling, and frailty, eventually culminating in loss of independence and death [5].”
BackgroundNew Criteria for `Obesity Disease' in Japan
Oda, E. (2006) · Circulation Journal · doi:10.1253/circj.70.150 · Cited by 783
Lim, S., Kim, J. H., Yoon, J. W., Kang, S. M., Choi, S. H., Park, Y. J., Kim, K. W., Lim, J. Y., Park, K. S., & Jang, H. C. (2010) · Diabetes Care · doi:10.2337/dc10-0107 · Cited by 588
Martin, S. S., Qasim, A., & Reilly, M. P. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.05.060 · Cited by 516 · cited 2×
“Leptin receptors have been shown to be down-regulated by leptin itself or via insulin resistance [10].”
BackgroundArterial stiffness is associated with low thigh muscle mass in middle-aged to elderly men
Ochi, M., Kohara, K., Tabara, Y., Kido, T., Uetani, E., Ochi, N., Igase, M., & Miki, T. (2010) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2010.05.026 · Cited by 252 · cited 2×
“They attended the voluntary medical check-up program, ‘‘Anti-Aging Doc,’’ a program provided to general residents of Ehime Prefecture, Japan, specifically designed to evaluate agingrelated disorders, including atherosclerosis, cardiovascular disease, physical function, and mild cognitive impairment [15,16].”
BackgroundMethodSelf-citationArgilés, J. M., López-Soriano, J., Almendro, V., Busquets, S., & López-Soriano, F. J. (2005) · Medicinal Research Reviews · doi:10.1002/med.20010 · Cited by 194 · cited 1×
“Exogenous leptin has also been shown to reduce protein synthesis in myocytes [22].”
Background
Cited by
Sarcopenic obesity: a critical appraisal of the current evidence
Prado, C. M. M., Wells, J. C. K., Smith, S. R., Stephan, B. C. M., & Siervo, M. (2012) · Clinical Nutrition · doi:10.1016/j.clnu.2012.06.010 · Cited by 589
Donini, L. M., Busetto, L., Bauer, J. M., Bischoff, S., Boirie, Y., Cederholm, T., Cruz-Jentoft, A. J., Dicker, D., Frühbeck, G., Giustina, A., et al. (2020) · Clinical Nutrition · doi:10.1016/j.clnu.2019.11.024 · Cited by 326
Müller, M. J., Lagerpusch, M., Enderle, J., Schautz, B., Heller, M., & Bosy‐Westphal, A. (2012) · Obesity Reviews · doi:10.1111/j.1467-789x.2012.01033.x · Cited by 292
“When compared with visceral obese patients, insulin sensitivity was further decreased in the ‘visceral + sarcopenic obese’ (28).”
BackgroundLiu, C., Wong, P. Y., Chung, Y. L., Chow, S. K., Cheung, W. H., Law, S. W., Chan, J. C. N., & Wong, R. M. Y. (2023) · Obesity Reviews · doi:10.1111/obr.13534 · Cited by 247
“for WC, over 90 cm in men and 85 cm in women were most frequently used to define central obesity, whereas two studies used the definition of visceral fat over 100 cm(2).(43,46) Five studies combined the criteria including BF% or BMI to diagnose obesity.”
BackgroundMethodThe implications of sarcopenia and sarcopenic obesity on cardiometabolic disease
Kim, T. N., & Choi, K. M. (2015) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25077 · Cited by 225
“Plasma levels of leptin are highest in individuals with SO followed by simple obesity, even after adjusting for age and body weight [Kohara et al., 2011].”
BackgroundMethodMeex, R. C. R., Blaak, E. E., & van Loon, L. J. C. (2019) · Obesity Reviews · doi:10.1111/obr.12862 · Cited by 211
Sarcopenic obesity: Emerging mechanisms and therapeutic potential
Axelrod, C. L., Dantas, W. S., & Kirwan, J. P. (2023) · Metabolism · doi:10.1016/j.metabol.2023.155639 · Cited by 204
“Remarkably, circulating leptin seems to be increased in patients with sarcopenic obesity compared to non-sarcopenic controls, suggesting that the up-regulation of leptin is likely due to resistance to its action, thus blunting the positive effects of leptin in skeletal muscle [19–21].”
BackgroundSarcopenic obesity in aging population: current status and future directions for research
Kohara, K. (2014) · Endocrine · doi:10.1007/s12020-013-9992-0 · Cited by 171
Self-citationSarcopenic obesity in cirrhosis—The confluence of 2 prognostic titans
Eslamparast, T., Montano‐Loza, A. J., Raman, M., & Tandon, P. (2018) · Liver International · doi:10.1111/liv.13876 · Cited by 123
Role of hormones in sarcopenia
(2021) · Vitamins and Hormones · doi:10.1016/bs.vh.2020.12.021 · Cited by 92
Creatinine-to-cystatin C ratio as a marker of skeletal muscle mass in older adults: J-SHIPP study
Tabara, Y., Kohara, K., Okada, Y., Ohyagi, Y., & Igase, M. (2019) · Clinical Nutrition · doi:10.1016/j.clnu.2019.07.027 · Cited by 105
Self-citationSarcopenic obesity: An appraisal of the current status of knowledge and management in elderly people
Molino, S., Dossena, M., Buonocore, D., & Verri, M. (2016) · The Journal of nutrition, health and aging · doi:10.1007/s12603-015-0631-8 · Cited by 91
Searching for the link between inflammaging and sarcopenia
Wang, T. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101611 · Cited by 98
Shida, T., Akiyama, K., Oh, S., Sawai, A., Isobe, T., Okamoto, Y., Ishige, K., Mizokami, Y., Yamagata, K., Onizawa, K., et al. (2017) · Journal of Gastroenterology · doi:10.1007/s00535-017-1377-3 · Cited by 93
“In both men and women, serum leptin levels have been reported to have a negative correlation with the cross-sectional area of femoral muscles [29].”
InfluentialThe critical role of oxidative stress in sarcopenic obesity
Gonzalez, A., Simon, F., Achiardi, O., Vilos, C., Cabrera, D., & Cabello-Verrugio, C. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/4493817 · Cited by 79
“High leptin levels in aging and obesity upregulate the proinflammatory cytokines IL-6 and TNF-α, reducing insulin-like growth factor 1 (IGF1) activity and decreasing their anabolic actions on skeletal muscle [14, 43, 44].”
BackgroundBody Size Phenotypes and Low Muscle Mass: The Korean Sarcopenic Obesity Study (KSOS)
Kim, T. N., Park, M. S., Yang, S. J., Yoo, H. J., Kang, H. J., Song, W., Seo, J. A., Kim, S. G., Kim, N. H., Baik, S. H., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3292 · Cited by 73
“Low muscle mass was defined as tmCSA/weight of 1 SD below the sex-specific mean value for the young reference group (20, 21).”
BackgroundCould very low-calorie ketogenic diets turn off low grade inflammation in obesity? Emerging evidence
Barrea, L., Caprio, M., Watanabe, M., Cammarata, G., Feraco, A., Muscogiuri, G., Verde, L., Colao, A., & Savastano, S. (2022) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2022.2054935 · Cited by 68
Serum Leptin Concentration is Associated with Incident Frailty in Older Adults
Lana, A., Valdés-Bécares, A., Buño, A., Rodríguez-Artalejo, F., & Lopez-Garcia, E. (2017) · Aging and disease · doi:10.14336/ad.2016.0819 · Cited by 62
“Interestingly, there is evidence that leptin concentrations are elevated in sarcopenic obesity (31), which in turn is an important risk factor for frailty (1,2,32).”
BackgroundArterial stiffness in sarcopenic visceral obesity in the elderly: J-SHIPP study
Kohara, K., Ochi, M., Tabara, Y., Nagai, T., Igase, M., & Miki, T. (2012) · International Journal of Cardiology · doi:10.1016/j.ijcard.2012.04.033 · Cited by 66
Self-citationLiu, H.-W., Chang, Y.-C., Chan, Y.-C., Hu, S.-H., Liu, M.-Y., & Chang, S.-J. (2020) · Biogerontology · doi:10.1007/s10522-020-09867-x · Cited by 60
Banitalebi, E., Faramarzi, M., Ghahfarokhi, M. M., SavariNikoo, F., Soltani, N., & Bahramzadeh, A. (2020) · Experimental Gerontology · doi:10.1016/j.exger.2020.110884 · Cited by 51
Minniti, G., Pescinini-Salzedas, L. M., Minniti, G. A. D. S., Laurindo, L. F., Barbalho, S. M., Sinatora, R. V., Sloan, L. A., Haber, R. S. D. A., Araújo, A. C., Quesada, K. R., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113452 · Cited by 56
The Impact of Dysmetabolic Sarcopenia Among Insulin Sensitive Tissues: A Narrative Review
Armandi, A., Rosso, C., Caviglia, G. P., Ribaldone, D. G., & Bugianesi, E. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.716533 · Cited by 48
“Leptin, secreted by adipose tissue, acts as a pro-inflammatory hormone; serum levels of leptin are higher in subjects with SO, rather than in those with either sarcopenia or visceral obesity alone (41).”
BackgroundSarcopenia and cachexia: molecular mechanisms and therapeutic interventions
Wang, T., Zhou, D., & Hong, Z. (2025) · MedComm · doi:10.1002/mco2.70030 · Cited by 46
Elevated leptin levels induce inflammation through IL-6 in skeletal muscle of aged female rats
Tazawa, R., Uchida, K., Fujimaki, H., Miyagi, M., Inoue, G., Sekiguchi, H., Murata, K., Takata, K., Kawakubo, A., & Takaso, M. (2019) · BMC Musculoskeletal Disorders · doi:10.1186/s12891-019-2581-5 · Cited by 50
Manoy, P., Anomasiri, W., Yuktanandana, P., Tanavalee, A., Ngarmukos, S., Tanpowpong, T., & Honsawek, S. (2017) · Biomarkers · doi:10.1080/1354750x.2017.1315615 · Cited by 42
Strakovsky, R. S., Lezmi, S., Flaws, J. A., Schantz, S. L., Pan, Y., & Helferich, W. G. (2013) · Toxicological Sciences · doi:10.1093/toxsci/kft331 · Cited by 45
“, 2011), sarcopenia (Kohara et al., 2011), and altered bone density (Zhuo et al.”
BackgroundBaad, V. M. A., Bezerra, L. R., de Holanda, N. C. P., dos Santos, A. C. O., da Silva, A. A. M., Bandeira, F., & Cavalcante, T. C. F. (2022) · Obesity Surgery · doi:10.1007/s11695-022-06335-y · Cited by 40
“(2011) [38], whose muscle mass values had a negative and independent relationship with leptin, and by Shibasaki et al.”
BackgroundWilhelmsen, A., Tsintzas, K., & Jones, S. W. (2021) · GeroScience · doi:10.1007/s11357-021-00322-4 · Cited by 44
Body composition and survival in the early clinical trials setting
Rodrigues, H. V., Baracos, V. E., Wheler, J. J., Parsons, H. A., Hong, D. S., Naing, A., Fu, S., Falchoock, G., Tsimberidou, A. M., Piha-Paul, S. A., et al. (2013) · European Journal of Cancer · doi:10.1016/j.ejca.2013.06.026 · Cited by 43
Examining the Association Between Serum Leptin and Sarcopenic Obesity
Yang, Z., & Chen, W. (2021) · Journal of Inflammation Research · doi:10.2147/jir.s320445 · Cited by 35
Influence of Severe Sarcopenia on Cardiovascular Risk Factors in Nonobese Men
Abe, T., Thiebaud, R. S., Loenneke, J. P., Bemben, M. G., Loftin, M., & Fukunaga, T. (2012) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2012.0057 · Cited by 36
“Recently, two studies 8,9 investigated the lipid and lipoprotein profile to compare between sarcopenia and nonsarcopenia obese and nonobese older men and women.”
Role of Adipokines in Sarcopenia
Lu, W., Feng, W., Lai, J., Yuan, D., Xiao, W., & Li, Y. (2023) · Chinese Medical Journal · doi:10.1097/cm9.0000000000002255 · Cited by 34
“One is leptin resistance that mainly manifests as hyperleptinemia and is common in obese individuals.([117]) Leptin resistance weakens normal leptin signal transduction, impairs the oxidation of fatty acids in muscle([118]) and increases the infiltration of intermuscular fat,([119,120]) which ultimately leads to skele…”
BackgroundKarvonen-Gutierrez, C. A., Zheng, H. T., Mancuso, P., & Harlow, S. D. (2015) · The Journals of Gerontology Series A · doi:10.1093/gerona/glv123 · Cited by 34
“Among middle-aged to elderly subjects, individuals with both sarcopenia and visceral obesity had higher leptin levels as compared with those with sarcopenia or visceral obesity alone (37).”
BackgroundTeixeira, L. A. D. C., Soares, L. A., da Fonseca, S. F., Gonçalves, G. T., dos Santos, J. M., Viegas, Â. A., Parentoni, A. N., Figueiredo, P. H. S., Mendonça, V. A., & Lacerda, A. C. R. (2024) · Scientific Reports · doi:10.1038/s41598-024-76417-7 · Cited by 42
“The deposition of lipids and their metabolites in muscle tissue 24,35 can induce a reduction in GLUT4 expression, compromising insulin signaling, resulting in reduced glucose uptake, increased oxidation of fatty acids in mitochondria, greater oxidative stress, inflammation and sarcopenia 11,18,36 .”
BackgroundLiang, Z., & Zhang, L. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1733798 · Cited by 39
“Notably, leptin concentrations were markedly elevated in individuals with sarcopenic visceral obesity (5.7 μg/L in men) compared to those with visceral obesity alone (4.3 μg/L) or no sarcopenia/obesity (1.9 μg/L), suggesting a link between leptin, visceral fat, and muscle mass (Kohara et al., 2011).”
InfluentialNovel perspectives on leptin in osteoarthritis: Focus on aging
Liu, Z., Xie, W., Li, H., Liu, X., Lu, Y., Lu, B., Deng, Z., & Li, Y. (2023) · Genes & Diseases · doi:10.1016/j.gendis.2023.101159 · Cited by 37
“Kohara et al 105 reported a positive link between plasma leptin levels and sarcopenic obesity and an inverse relationship between plasma leptin levels and thigh muscle cross-sectional area after adjusting for age, body weight, and visceral obesity.”
BackgroundLangkilde, A., Petersen, J., Henriksen, J. H., Jensen, F. K., Gerstoft, J., Eugen‐Olsen, J., & Andersen, O. (2015) · Immunity & Ageing · doi:10.1186/s12979-015-0036-x · Cited by 33
“FMI and tLMI and lLMI were positively associated, in agreement with the increase in lean mass required to carry an increased fat mass previously reported [31].”
ResultMizuno, N., Seko, Y., Kataoka, S., Okuda, K., Furuta, M., Takemura, M., Taketani, H., Hara, T., Umemura, A., Nishikawa, T., et al. (2018) · Journal of Gastroenterology · doi:10.1007/s00535-018-1485-8 · Cited by 28
Sarcopenia in the Cirrhotic Patient: Current Knowledge and Future Directions
Warner, E. R., & Satapathy, S. K. (2022) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2022.06.005 · Cited by 31
Ohara, M., Kohara, K., Tabara, Y., Igase, M., & Miki, T. (2014) · Journal of Hypertension · doi:10.1097/hjh.0000000000000394 · Cited by 33
“Images were obtained with a minimal slice width of 5mm and analyzed using OsiriX software (OsiriX Foundation, Geneva, Switzerland) [7,18].”
Self-citationKao, T., Peng, T., Chen, W., Chi, Y., Chen, C., & Yang, W. (2021) · Journal of Inflammation Research · doi:10.2147/jir.s335694 · Cited by 25
“mass, body fat percentage, and FMR, consistent with the findings in previous studies.(33,34) Interestingly, serum leptin levels were also positively associated with SMI among participants in our study.”
ResultEmerging Treatment Options for Sarcopenia in Chronic Liver Disease
Kim, Y. (2021) · Life · doi:10.3390/life11030250 · Cited by 26
“Leptin, one of the secreted adipokines from inflamed adipose tissue, contributes to the loss of skeletal muscle [90].”
Obesity and Mobility in Advancing Age: Mechanisms and Interventions to Preserve Independent Mobility
Vincent, H. K., & Mathews, A. (2013) · Current Obesity Reports · doi:10.1007/s13679-013-0059-6 · Cited by 27
“Intriguing associative data shows that circulating leptin levels are highest in older adults with sarcopenic obesity compared to those who are sarcopenic or viscerally obese alone [16].”
BackgroundBody composition in sarcopenic obesity: systematic review of the literature
Donini, L. M., Poggiogalle, E., Migliaccio, S., Aversa, A., & Pinto, A. (2013) · Mediterranean Journal of Nutrition and Metabolism · doi:10.1007/s12349-013-0135-1 · Cited by 31
Amevor, A. A., Yodoshi, T., Trout, A. T., Dillman, J. R., Singh, R., Jarvis, R., Fei, L., Liu, C., Taylor, A. E., Miethke, A. G., et al. (2021) · Liver International · doi:10.1111/liv.15108 · Cited by 23
“Subcutaneous fat thickness (mm)a 15 (11, 26) 17 (11, 28) 14 (9, 26) .”
Metabolic characterization of overweight and obese adults
Hirsch, K. R., Smith‐Ryan, A. E., Blue, M. N. M., Mock, M. G., Trexler, E. T., & Ondrak, K. S. (2016) · The Physician and Sportsmedicine · doi:10.1080/00913847.2016.1248222 · Cited by 26
“Abnormally low LM, as well as poor-quality LM, similar to that observed in sarcopenic obesity, have been previously associated with metabolic dysfunction and insulin resistance, even in normalweight individuals [40,41].”
Igase, M., Kohara, K., Tabara, Y., Nagai, T., Ochi, N., Kido, T., Ochi, M., & Miki, T. (2012) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e318259c04e · Cited by 22
“Images were analyzed using the OsiriX software (OsiriX Foundation, Geneva, Switzerland), and fat area was calculated using this software, with attenuation ranging from j150 to j50 Hounsfield units.(9)”
MethodSelf-citationKohara, K., Ochi, M., Okada, Y., Yamashita, T., Ohara, M., Kato, T., Nagai, T., Tabara, Y., Igase, M., & Miki, T. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2014.05.940 · Cited by 20
Self-citationYamashita, T., Kohara, K., Tabara, Y., Ochi, M., Nagai, T., Okada, Y., Igase, M., & Miki, T. (2014) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2014.05.050 · Cited by 20
Self-citationTeixeira, L. A. D. C., dos Santos, J., Parentoni, A. N., Lima, L. D., Duarte, T. C., Brant, F. P., Neves, C. D. C., Pereira, F. S. M., de Avelar, N. C. P., Danielewicz, A. L., et al. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11237175 · Cited by 19
“In accordance, Kohara et al. (2011) observed that high leptin blood levels are greater in individuals with sarcopenia and visceral obesity than in individuals with only one condition, suggesting that leptin blood levels are associated with sarcopenia, independent of visceral fat [31].”
BackgroundJayawardena, T. U., Kim, S., & Jeon, Y. (2021) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2021.1969889 · Cited by 15
Haam, J.-H., Kim, Y., Koo, H. S., Haam, J., Seo, N., Kim, H. Y., Park, K., Park, K., & Kim, M. J. (2015) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2015.12.003 · Cited by 15
Tabara, Y., Okada, Y., Ochi, M., Ohyagi, Y., & Igase, M. (2023) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/ggi.14582 · Cited by 14
Self-citationEndocrinological aspects of sarcopenic obesity
Minnetti, M., Poggiogalle, E., Frigerio, F., Piciocchi, C., Pierantozzi, G., Vincenzo, O. D., Pinto, A., Gianfrilli, D., Isidori, A. M., Migliaccio, S., et al. (2026) · Annals of Medicine · doi:10.1080/07853890.2026.2626085 · Cited by 14
“Elevated leptin concentrations have been reported in individuals with SO [145,146], also exceeding those observed in either sarcopenia or visceral obesity alone [145].”
Effects of Whey Peptide Supplementation on Sarcopenic Obesity in High-Fat Diet-Fed Mice
Lim, G., & Lim, Y. (2022) · Nutrients · doi:10.3390/nu14204402 · Cited by 13
“In addition, a study indicated that leptin is a linkage between visceral obesity and sarcopenia [57].”
BackgroundPowell, M., Lara, J., Mocciaro, G., Prado, C. M. M., Battezzati, A., Leone, A., Tagliabue, A., Amicis, R. S. D., Vignati, L., Bertoli, S., et al. (2016) · Clinical Obesity · doi:10.1111/cob.12165 · Cited by 12
“obesity, while appendicular skeletal muscle mass (16,20–23), skeletal mass index (5,17,24), skeletal muscle mass percentage (9,12), FFM index (FFMI) (8) and thigh muscle crosssectional area (25) have all been parameters used to define sarcopenia.”
BackgroundMethodNegative correlation between leptin serum levels and sarcopenia in hemodialysis patients.
Lin, Y., Wang, C., Lai, Y.-H., Kuo, C., Syu, R., & Hsu, B. (2018) · PubMed Central · Cited by 17
Loureiro, L. M., Lessa, S., Mendes, R., Pereira, S., Saboya, C. J., & Ramalho, A. (2019) · Nutrients · doi:10.3390/nu11092125 · Cited by 11
“Obesity is related to the highest prevalence of diseases such as the metabolic bone [2,3], which are characterized by alterations in some biochemical markers [5,6], favored by the inflammatory profile of obesity [7], besides the hormonal, enzymatic, and metabolic [8,9] alterations to which these individuals are more e…”
BackgroundHan, E., Kim, M. K., Im, S., Kim, H. S., Kwon, T. K., & Jang, B. K. (2022) · Gut and Liver · doi:10.5009/gnl220133 · Cited by 11
“Additionally, evidences support that high sodium diet endogenous fructose production and accelerate leptin resistance which can drive sarcopenia and fatty liver disease.(24,25) Thus, it appears that a high sodium intake implicates both NAFLD and sarcopenia, although the underlying mechanisms of high salt intake on liv…”
BackgroundJuby, A. G. (2014) · Maturitas · doi:10.1016/j.maturitas.2014.05.013 · Cited by 11
Wang, H.-L., Liu, L.-L., Tan, Z.-Y., Zhou, Y., Zhang, J., Zhai, L., Xie, Q., & Liu, R.-H. (2025) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2025.104992 · Cited by 10
Morioka, T., Mori, K., Motoyama, K., & Emoto, M. (2016) · Springer eBooks · doi:10.1007/978-4-431-55720-3_14 · Cited by 11
Fukuda, D. H., Smith‐Ryan, A. E., Kendall, K. L., Moon, J. R., & Stout, J. R. (2013) · Experimental Gerontology · doi:10.1016/j.exger.2013.10.005 · Cited by 10
“This relationshipmay be a result of adipocyte–myocyte crosstalk as highlighted by the findings of Kohara et al. (2011) that showed heightened leptin concentrations in subjects with sarcopenic visceral obesity compared to obesity or sarcopenia alone.”
BackgroundMiyawaki, S., Kohara, K., Kido, T., Tabara, Y., Igase, M., Miki, T., & Sayama, K. (2015) · Skin Research and Technology · doi:10.1111/srt.12223 · Cited by 9
“CT images were obtained with a minimal slice width of 5 mm and analyzed using OsiriX software (OsiriX Foundation, Geneva, Switzerland) (6).”
MethodSelf-citationNakanishi, T., Tsujii, M., Asano, T., Iino, T., & Sudo, A. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2019.01596 · Cited by 11
Korzonek-Szlacheta, I., Hudzik, B., Zubelewicz‐Szkodzińska, B., Czuba, Z. P., Szlacheta, P., & Tomasik, A. R. (2024) · Nutrients · doi:10.3390/nu16081227 · Cited by 8
“A study by Kohara et al. [33] on sarcopenic obesity may serve as an explanation for the observation by Hubbard et al. [32].”
ResultShibasaki, K., Yamada, S., Akishita, M., & Ogawa, S. (2018) · Journal of the Endocrine Society · doi:10.1210/js.2018-00104 · Cited by 10
“[5] demonstrated that the plasma leptin level was greater in older adults with sarcopenia and sarcopenic obesity compared with normal healthy older adults and those with obesity without sarcopenia.”
BackgroundResultInfluentialGil, T., Kim, J. Y., Shin, J., Jang, D.-H., Park, S. S., Kim, S. W., Shin, C. S., Jeon, O. H., & Kong, S. H. (2025) · The journal of nutrition health & aging · doi:10.1016/j.jnha.2025.100607 · Cited by 9
Xu, X., Qian, Y., Jin, K., Chen, J., Fu, J., Chen, C., & Zhu, Z. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1289909 · Cited by 7
“And several studies showed decreased levels of ghrelin and leptin in patients with LSMM (Kohara et al., 2011; Serra-Prat et al., 2015).”
BackgroundMogi, M., Kohara, K., Tabara, Y., Tsukuda, K., Igase, M., & Horiuchi, M. (2018) · Hypertension Research · doi:10.1038/s41440-018-0021-9 · Cited by 7
Self-citationDetrimental relevance of Helicobacter pylori infection with sarcopenia
Wu, S., & Chen, W. (2021) · Gut Pathogens · doi:10.1186/s13099-021-00464-y · Cited by 8
“Studies have discussed changes of leptin levels in sarcopenia patients, and recognized its role in aging muscle [26].”
BackgroundYang, M., Zhou, F., Wang, C., sun, T., zhao, W., Liu, L., Meng, Y., & tian, L. (2026) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00473.2025 · Cited by 5
Relationship of serum leptin and 25-hydroxyvitamin D in knee osteoarthritis patients
Manoy, P. (2018) · Chulalongkorn Medical Journal · doi:10.58837/chula.cmj.62.6.10 · Cited by 6
“Chula Med J 2018 Nov – Dec;62(6): 1037 - 47 Background Osteoarthritis (OA) is a degenerative articular disease that involves progressive alterations in all joint structures resulting from aging and overuse activity.”
BackgroundInfluentialNeto, L. S. S., Medeiros, A., Travassos, A., Osório, N. B., & Nunes, G. F. (2019) · Revista de Nutrição · doi:10.1590/1678-9865201932e180237 · Cited by 5
“The etiology of this morbidity includes the complex interactions between the causal factors of sarcopenia and obesity, such as a sedentary lifestyle, an inadequate diet, weight loss, IR, decreased growth and testosterone hormones and the production of proinflammatory cytokines by the adipose tissue [4,5-7].”
BackgroundResultInfluentialWei, Z., Yu, T., Jin, X., Ma, G., & Meng, X. J. (2025) · PLoS ONE · doi:10.1371/journal.pone.0322928 · Cited by 7
“In addition, it has been shown that leptin levels are higher in patients with sarcopenic visceral obesity than in patients with sarcopenia alone [40].”
Xu, J., Peng, H. F., Kuang, R., Han, Z., Zhou, H., Hu, M., Guo, Y., Xu, Z., DaoyuanWang, Ma, R., et al. (2025) · Genomics · doi:10.1016/j.ygeno.2025.110998 · Cited by 5
Ghoch, M. E., Rossi, A. P., Verde, L., Barrea, L., Muscogiuri, G., Savastano, S., & Colao, A. (2022) · Panminerva Medica · doi:10.23736/s0031-0808.22.04784-x · Cited by 4
Nagaoka, U., Shimizu, T., & Uchihara, T. (2015) · Neurological Sciences · doi:10.1007/s10072-015-2189-y · Cited by 4
van Poelje, M. W., van de Lagemaat, M., Lafeber, H. N., van Weissenbruch, M. M., & Rotteveel, J. (2014) · Hormone Research in Paediatrics · doi:10.1159/000369393 · Cited by 4
Conceptos básicos sobre obesidad sarcopénica en el adulto mayor
Zuñiga, R. (2015) · Revista Clínica Escuela de Medicina UCR-HSJD · doi:10.15517/rc_ucr-hsjd.v5i3.19919 · Cited by 6
Cheng, G., Zhou, Y., Wang, Y., Wang, C., & Xu, J. (2025) · Frontiers in Public Health · doi:10.3389/fpubh.2025.1609325 · Cited by 2
“Elevated levels of leptin, indicative of leptin resistance, are closely associated with decreased muscle mass in middle-aged and older adults (29, 30).”
Sarcopenic obesity and metabolic disorders in ageing
Kurmaev, D. P., Bulgakova, S. V., Treneva, E. V., Косарева, О. В., Sharonova, L. A., Dolgikh, Y. A., & Merzlova, P. Y. (2025) · Экспериментальная и клиническая гастроэнтерология · doi:10.31146/1682-8658-ecg-235-3-134-147 · Cited by 2
Landi, F., Onder, G., & Rolland, Y. (2012) · Wiley eBooks · doi:10.1002/9781118338032.ch20 · Cited by 4
Santhakumar, C., Bartlett, A. S. J. R., Plank, L. D., Wells, C. I., Wu, L., Gane, E. J., & McCall, J. L. (2020) · GastroHep · doi:10.1002/ygh2.412 · Cited by 3
“Tumour size (mm), median (range) 45 (3-230) 56 (12-230) 44 (3-200) .”
Obesity, inflammation and muscle weakness
Hasselgren, P.-O. J. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-90960-0.00014-x · Cited by 1
Tajik, A., Mahdavizadeh, V., Hadizadeh, F., & Shakour, N. (2025) · Current Diabetes Reviews · doi:10.2174/0115733998349193250207045239 · Cited by 1
Association between sleep duration and sarcopenic obesity: The mediating role of hemoglobin level
Zhao, X., Chen, J., Zhang, L., Wen, H., Han, L., & Ding, H. (2026) · PLoS ONE · doi:10.1371/journal.pone.0347177 · Cited by 2
Clinical aspect of sarcopenic obesity
Kohara, K. (2013) · Nippon Ronen Igakkai Zasshi Japanese Journal of Geriatrics · doi:10.3143/geriatrics.50.773 · Cited by 1
Self-citationMiyagami, T., Yokokawa, H., Fujibayashi, K., Fukuda, H., Hisaoka, T., & Naito, T. (2020) · Osteoporosis and Sarcopenia · doi:10.1016/j.afos.2020.02.004 · Cited by 3
“Similarly, another human study showed that serum leptin levels were related to sarcopenic obesity [20].”
BackgroundNoer, E. R., Rose, S., Fajrani, A. M., Rachma, D. E., Limijadi, E. K. S., & Fitranti, D. Y. (2022) · Jurnal Gizi dan Dietetik Indonesia (Indonesian Journal of Nutrition and Dietetics) · doi:10.21927/ijnd.2022.10(1).30-36 · Cited by 1
Kohara, K. (2013) · Nippon Ronen Igakkai Zasshi Japanese Journal of Geriatrics · doi:10.3143/geriatrics.50.352
Self-citationO’Leary, M. F. (2018) · University of Birmingham Institutional Research Archive (University of Birmingham)
Landi, F., Onder, G., & Rolland, Y. (2021) · Wiley eBooks · doi:10.1002/9781119597896.ch25
Vitamin d supplementation and physical performance in knee osteoarthritis patients
Manoy, P. (2016) · Chula Digiverse · doi:10.58837/chula.the.2016.1715
Евгеньевна, К. К., Цыганкова, Д. П., Геннадьевна, Н. А., Kareeva, A. I., Коков, А. Н., Bazdyrev, E. D., Каретникова, В. Н., & Барбараш, О. Л. (2024) · Diagnostics · doi:10.3390/diagnostics14232663
“In the study by K. Kohara et al. [29], leptin levels were higher in the serum of elderly patients with sarcopenia and sarcopenic obesity compared with healthy elderly participants.”
Lee, Y.-H., Bai, W.-B., Lin, Y., Su, G.-T., & Li, W.-C. (2026) · International Journal of General Medicine · doi:10.2147/ijgm.s584966
“39 (4) Myosteatosis, characterized by fat infiltration into muscle tissue, impairs muscle mass and function, leading to inflammation, fibrosis, and metabolic dysfunction, thereby further contributing to muscle atrophy.”
Integrative Analysis Uncover the Effects and Multi‐Omics Features of Thigh Muscle Fat Infiltration
Zhang, Y., Qin, D., Zong, X., Haowei, C., Simin, W., Xu, S., Kunyan, 王. W., Xiaoshuai, 王. W., Jianwei, Z., Zhu, Z., et al. (2026) · Aging Cell · doi:10.1111/acel.70690
Metadata
- Authors
- Kohara, K., Ochi, M., Tabara, Y., Nagai, T., Igase, M., & Miki, T.
- Affiliations
- Ehime University (JP)
- Corresponding author
- Kohara, Katsuhiko
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2011-09-09
- Volume
- 6
- Issue
- 9
- Pages
- e24633
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3170390
- OpenAlex
- W2053329933
- Cited by
- 99
- References
- 25
- Citations by year
- 2026: 6 · 2025: 8 · 2024: 4 · 2023: 4 · 2022: 12 · 2021: 11 · 2020: 5 · 2019: 6 · 2018: 7 · 2017: 3 · 2016: 4 · 2015: 8 · 2014: 6 · 2013: 9 · 2012: 6
- FWCI
- 4.58
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Ministry of Education, Culture, Sports, Science and Technology
- Japan Society for the Promotion of Science (22659143, 20390185, 23390188)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Keywords
- leptin, sarcopenic obesity, visceral obesity, sarcopenia, thigh muscle cross-sectional area, visceral fat area, plasma leptin, muscle mass, older adults, adipocytes, muscle cells
- MeSH terms
- Aged, Female, Humans, Male, Middle Aged, Adipocytes, Muscle, Skeletal, Leptin, Muscle Cells, Intra-Abdominal Fat, Sarcopenia, Obesity, Abdominal
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.